comparemela.com
Home
Live Updates
Genezen Secures $18.5 Million in Growth Equity to Expand Vir
Genezen Secures $18.5 Million in Growth Equity to Expand Vir
Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities
/PRNewswire/ -- Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5...
Related Keywords
Indiana ,
United States ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Boston ,
Massachusetts ,
Connor Halverson ,
Steven Favaloro ,
Prnewswire Genezen ,
David Anderson ,
Contract Development ,
Manufacturing Organization ,
Linkedin ,
Ampersand Capital Partners ,
Ampersand Capital ,
With Ampersand ,
General Partner ,
Genezen ,